Phenylbiguanide

Phenylbiguanide (PBG) is a 5-HT3 agonist used to study the role of 5-HT3 receptors in the central nervous system.[1] It has been found to trigger dopamine release in the nucleus accumbens of rats.[2]

Phenylbiguanide
Legal status
Legal status
  • UN: Unscheduled
Identifiers
IUPAC name
  • 1-Phenylbiguanide
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.002.726
Chemical and physical data
FormulaC8H11N5
Molar mass177.211 g·mol−1
3D model (JSmol)
Melting point135–142 °C (275–288 °F)
SMILES
  • c1ccc(cc1)NC(=N)NC(=N)N
InChI
  • InChI=1S/C8H11N5/c9-7(10)13-8(11)12-6-4-2-1-3-5-6/h1-5H,(H6,9,10,11,12,13)
  • Key:CUQCMXFWIMOWRP-UHFFFAOYSA-N

Derivatives

  • Phenylbiguanide is used to make amanozine and benfosformin.

References

  1. Higgins GA, Joharchi N, Sellers EM (March 1993). "Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats". The Journal of Pharmacology and Experimental Therapeutics. Journal of Pharmacology and Experimental Therapeutics. 264 (3): 1440–9. PMID 8450478.
  2. Chen JP, van Praag HM, Gardner EL (March 1991). "Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens". Brain Research. Brain Research. 543 (2): 354–7. doi:10.1016/0006-8993(91)90050-6. PMID 1711914. S2CID 37426395.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.